Last reviewed · How we verify
Haemophilus Influenzae Pharyngitis
Approved treatments
- Amoxycillin · King George's Medical University
- Unasyn · Bristol-Myers Squibb
- Demethylchlortetracycline · Pfizer
- Amoxil · Generic (originally Beecham/GSK)
Broad-spectrum aminopenicillin that inhibits bacterial cell wall synthesis by binding penicillin-binding proteins. - Meclan · Johnson And Johnson
- Amoxicilli · Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Haemophilus Influenzae Pharyngitis patent landscape — cliff calendar, originator estates, attackable patents
- Haemophilus Influenzae Pharyngitis treatment landscape brief
- Haemophilus Influenzae Pharyngitis treatment updates RSS
Frequently asked questions about Haemophilus Influenzae Pharyngitis
What drugs treat Haemophilus Influenzae Pharyngitis?
Tracked treatments include Amoxycillin, Unasyn, Demethylchlortetracycline, Amoxil, Meclan, Amoxicilli.
What is the treatment for Haemophilus Influenzae Pharyngitis?
Standard treatment for Haemophilus Influenzae Pharyngitis includes Amoxycillin, Unasyn, Demethylchlortetracycline, Amoxil, Meclan. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Haemophilus Influenzae Pharyngitis patent cliff · Haemophilus Influenzae Pharyngitis CI report
- Treatment: Amoxycillin · King George's Medical University
- Treatment: Unasyn · Bristol-Myers Squibb
- Treatment: Demethylchlortetracycline · Pfizer
- Treatment: Amoxil · Generic (originally Beecham/GSK)
- Treatment: Meclan · Johnson And Johnson
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing